Morgan R. Brown - Jun 29, 2023 Form 4 Insider Report for Clene Inc. (CLNN)

Signature
/s/ Jerry Miraglia POA
Stock symbol
CLNN
Transactions as of
Jun 29, 2023
Transactions value $
$0
Form type
4
Date filed
7/3/2023, 01:50 PM
Previous filing
Feb 21, 2023
Next filing
Jun 11, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CLNN Stock Options (Right to buy) Award $0 +400K $0.00 400K Jun 29, 2023 Common Stock 400K $0.90 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option was granted on June 29, 2023 as an option for 400,000 shares of Common Stock under the Clene Inc. Amended 2020 Stock Plan at an exercise price of $0.90 per share. The options vest with respect to the first 25% of such shares on June 29, 2024 and then in 36 equal installments of the balance of the shares of Common Stock on the last day of each calendar month beginning July 29, 2024 until such shares are fully vested. If Clene Inc. has an NDA accepted by the FDA, 50% of the option shares shall vest on that date. If the FDA approves the accepted NDA, the then remaining unvested option shares shall vest on that date.